这是一篇来自已证抗体库的有关人类 CD38的综述,是根据212篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD38 抗体。
CD38 同义词: ADPRC 1; ADPRC1

BioLegend
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:100; 图 2s1b
BioLegend CD38抗体(Biolegend, 303510)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 2s1b). elife (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:200; 图 s10b
BioLegend CD38抗体(Biolegend, 303524)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s10b). Science (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 7b
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 7b). J Immunol (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD38抗体(BioLegend, 303532)被用于被用于流式细胞仪在人类样本上 (图 2a). Cell (2019) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 3g
BioLegend CD38抗体(BioLegend, HB-7)被用于被用于流式细胞仪在人类样本上 (图 3g). Sci Immunol (2019) ncbi
小鼠 单克隆(HIT2)
  • mass cytometry; 人类; 图 2b
BioLegend CD38抗体(Biolegend, 303502)被用于被用于mass cytometry在人类样本上 (图 2b). Cell (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3a
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3a). Arthritis Res Ther (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s3
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s3). Eur J Immunol (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2b
BioLegend CD38抗体(Biolegend, 303518)被用于被用于流式细胞仪在人类样本上 (图 2b). Nature (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s6d
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s6d). Cell (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD38抗体(Biolegend, 303502)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell (2018) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 s8a
BioLegend CD38抗体(BioLegend, HB-7)被用于被用于流式细胞仪在人类样本上 (图 s8a). Leukemia (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s5
BioLegend CD38抗体(Biolegend, 303532)被用于被用于流式细胞仪在人类样本上 (图 s5). J Clin Invest (2018) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 7a
BioLegend CD38抗体(BioLegend, 356618)被用于被用于流式细胞仪在人类样本上 (图 7a). Cell (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s2e
BioLegend CD38抗体(BioLegend, 303515)被用于被用于流式细胞仪在人类样本上 (图 s2e). Cell (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s7g
BioLegend CD38抗体(BioLegend, 303512)被用于被用于流式细胞仪在人类样本上 (图 s7g). Cell (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2018) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 s1a
BioLegend CD38抗体(Biolegend, HB-7)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Cell Sci (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2d
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2d). J Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1b). J Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s3
BioLegend CD38抗体(biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (表 s3). Cell (2017) ncbi
小鼠 单克隆(HIT2)
  • mass cytometry; 人类; 图 s3a
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于mass cytometry在人类样本上 (图 s3a). Science (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1b
BioLegend CD38抗体(BioLegend, 303510)被用于被用于流式细胞仪在人类样本上 (图 1b). Scand J Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • mass cytometry; 人类; 图 s8
BioLegend CD38抗体(BioLegend, 303502)被用于被用于mass cytometry在人类样本上 (图 s8). Nature (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s2
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (表 s2). Sci Rep (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(biolegend, HIT-2)被用于被用于流式细胞仪在人类样本上. Nature (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2a). Clin Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 小鼠; 图 2d
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在小鼠样本上 (图 2d). J Clin Invest (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:100; 图 1b
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1b). Cell Transplant (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:100; 图 1
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 1
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
小鼠 单克隆(HB-7)
BioLegend CD38抗体(Biolegend, 356608)被用于. Nat Commun (2016) ncbi
小鼠 单克隆(HB-7)
  • 流式细胞仪; 人类; 图 s4
BioLegend CD38抗体(Biolegend, HB-7)被用于被用于流式细胞仪在人类样本上 (图 s4). Nature (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
BioLegend CD38抗体(BioLegend, 303509)被用于被用于流式细胞仪在人类样本上 (图 1). Stem Cell Reports (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2). J Immunol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s1). Analyst (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2a). J Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
BioLegend CD38抗体(Biolegend, clone HIT2)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图  4
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图  4). Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
BioLegend CD38抗体(BIOLEGEND, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 免疫细胞化学; 人类; 图 1
BioLegend CD38抗体(BioLegend, 303509)被用于被用于免疫细胞化学在人类样本上 (图 1). Leukemia (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:80
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:80. J Immunol Methods (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 5
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 5). J Exp Med (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 5
BioLegend CD38抗体(Biolegend, # 303515)被用于被用于流式细胞仪在人类样本上 (图 5). Biomaterials (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s1
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (表 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1). Int Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). J Autoimmun (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4). Cytokine (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4). Immunol Cell Biol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(Biolegend, HIT2)被用于被用于流式细胞仪在人类样本上. Ann Rheum Dis (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
BioLegend CD38抗体(Biolegend, 303506)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS Pathog (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(BioLegend, HIT-2)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
BioLegend CD38抗体(BioLegend, HIT2)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
赛默飞世尔
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD38抗体(eBioscience, 17-0389-42)被用于被用于流式细胞仪在人类样本上 (图 1a). J Exp Med (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:1200; 图 1a
赛默飞世尔 CD38抗体(eBioscience, 25-0389-42)被用于被用于流式细胞仪在人类样本上浓度为1:1200 (图 1a). elife (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4a
赛默飞世尔 CD38抗体(Thermo Fisher, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4a). J Clin Invest (2018) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:50; 图 7a
赛默飞世尔 CD38抗体(eBioscience, 85-25-0388-41)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 7a). J Clin Invest (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1a). J Clin Invest (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD38抗体(Invitrogen, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1a). AIDS Res Hum Retroviruses (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD38抗体(Invitrogen, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2a). PLoS ONE (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD38抗体(Invitrogen, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2a). Arthritis Rheumatol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:100; 图 8
赛默飞世尔 CD38抗体(eBioscience, 17-0389)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 8). Haematologica (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1c
赛默飞世尔 CD38抗体(eBioscience, 25-0389)被用于被用于流式细胞仪在人类样本上 (图 1c). Haematologica (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s1
赛默飞世尔 CD38抗体(ThermoFisher, MHCD3817)被用于被用于流式细胞仪在人类样本上 (表 s1). Stem Cells (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1c
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1c). PLoS Pathog (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1). Immunol Res (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 小鼠; 图 4j
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在小鼠样本上 (图 4j). Nat Chem Biol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(e-bioscience, HIT-2)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2). J Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:50
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:50. Nat Med (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(38C03 (SPC32))
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 CD38抗体(Labvision, 38C03)被用于被用于免疫组化-石蜡切片在人类样本上. Arthritis Res Ther (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Invitrogen, MHCD3805)被用于被用于流式细胞仪在人类样本上. Oncotarget (2013) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上. Immunology (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(eBioscience, HIT2)被用于被用于流式细胞仪在人类样本上. J Hepatol (2014) ncbi
小鼠 单克隆(38C03 (SPC32))
  • 免疫组化-石蜡切片; 人类; 1:50; 表 2
赛默飞世尔 CD38抗体(Neomarkers, 38C03)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (表 2). PLoS ONE (2012) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD38抗体(Invitrogen, MHCD3817)被用于被用于流式细胞仪在人类样本上 (图 4). Nat Genet (2012) ncbi
小鼠 单克隆(AT13/5)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 CD38抗体(NeoMarker, AT1)被用于被用于免疫组化-石蜡切片在人类样本上. Diagn Pathol (2011) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1d
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1d). Nat Protoc (2008) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD38抗体(Invitrogen, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). Arthritis Rheum (2008) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag Laboratories, HB-7)被用于被用于流式细胞仪在人类样本上. J Immunol (2008) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Leukemia (2007) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD38抗体(Caltag, HIT 2)被用于被用于流式细胞仪在人类样本上 (图 1). Blood (2007) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT 2)被用于被用于流式细胞仪在人类样本上. Scand J Immunol (2006) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD38抗体(Caltag-Medsystems, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). Leuk Res (2007) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2006) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD38抗体(Caltag, HIT 2)被用于被用于流式细胞仪在人类样本上 (表 1). Haematologica (2006) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1A
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1A). J Transl Med (2006) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2005) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, MHCD3801)被用于被用于流式细胞仪在人类样本上. Haematologica (2003) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT-2)被用于被用于流式细胞仪在人类样本上. J Virol (2002) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD38抗体(Caltag Laboratories, clone HIT2)被用于被用于流式细胞仪在人类样本上 (图 2). Blood (2002) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2002) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD38抗体(Caltag, Clone HIT2)被用于被用于流式细胞仪在人类样本上 (图 2). Br J Haematol (2002) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1). Exp Hematol (2000) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Blood (2000) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Br J Haematol (1999) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4). J Immunol (1999) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Br J Haematol (1999) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Clin Exp Immunol (1998) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 5). Photochem Photobiol (1998) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Bone Marrow Transplant (1998) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). J Exp Med (1997) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
赛默飞世尔 CD38抗体(Caltag, HIT2)被用于被用于流式细胞仪在人类样本上. Blood (1995) ncbi
美天旎
人类 单克隆(REA572)
  • 流式细胞仪; 人类; 图 3d
美天旎 CD38抗体(Miltenyi Biotec, REA572)被用于被用于流式细胞仪在人类样本上 (图 3d). N Biotechnol (2018) ncbi
小鼠 单克隆(IB6)
  • 流式细胞仪; 人类; 图 4c
美天旎 CD38抗体(Miltenyi Biotec, IB6)被用于被用于流式细胞仪在人类样本上 (图 4c). Int J Mol Sci (2017) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR4106)
  • 免疫组化-石蜡切片; 人类; 表 s7
艾博抗(上海)贸易有限公司 CD38抗体(Abcam, EPR4106)被用于被用于免疫组化-石蜡切片在人类样本上 (表 s7). Cell (2017) ncbi
小鼠 单克隆(FS02)
  • 免疫印迹; 小鼠; 1:1000; 图 5e
艾博抗(上海)贸易有限公司 CD38抗体(Abcam, ab1173)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5e). Mol Biol Cell (2016) ncbi
domestic rabbit 单克隆(EPR4106)
  • 免疫细胞化学; 人类; 1:100; 图 3
艾博抗(上海)贸易有限公司 CD38抗体(Abcam, ab108403)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 3). Lab Chip (2015) ncbi
安迪生物R&D
小鼠 单克隆(240742)
  • 流式细胞仪; 人类; 图 3a
安迪生物R&D CD38抗体(R&D Systems, FAB2404A)被用于被用于流式细胞仪在人类样本上 (图 3a). J Appl Physiol (1985) (2017) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(T16)
  • 流式细胞仪; 人类; 图 1b
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, T16)被用于被用于流式细胞仪在人类样本上 (图 1b). Blood (2017) ncbi
小鼠 单克隆(LS198-4-3)
  • 流式细胞仪; 人类; 图 2a
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, LS198-4-3)被用于被用于流式细胞仪在人类样本上 (图 2a). Clin Immunol (2017) ncbi
小鼠 单克隆(LS198-4-3)
  • 流式细胞仪; 人类; 1:25; 图 2
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, LS198-4-3)被用于被用于流式细胞仪在人类样本上浓度为1:25 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(T16)
  • 其他; 人类; 200 ug/ml; 图 3
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, IM0366)被用于被用于其他在人类样本上浓度为200 ug/ml (图 3). J Extracell Vesicles (2016) ncbi
小鼠 单克隆(T16)
  • 流式细胞仪; 人类; 表 4
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman Coulter, T16)被用于被用于流式细胞仪在人类样本上 (表 4). Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(LS198-4-3)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD38抗体(Beckman-Coulter, LS198-4-3)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
Stemcell Technologies
小鼠 单克隆(AT-1)
  • 流式细胞仪; 猕猴; 1:200; 图 3g
干细胞技术 CD38抗体(干细胞技术, 60131FI)被用于被用于流式细胞仪在猕猴样本上浓度为1:200 (图 3g). Nature (2019) ncbi
Cytognos
单克隆(LD38)
  • 流式细胞仪; 人类; 表 1
Cytognos CD38抗体(Cytognos, LD38)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
碧迪BD
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s1b
碧迪BD CD38抗体(BD Biosciences, 347687)被用于被用于流式细胞仪在人类样本上 (图 s1b). Cell (2019) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 1a). Blood Cancer J (2019) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:50; 图 4b
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 4b). Nat Commun (2019) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD38抗体(BD Horizon, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3a). J Clin Invest (2019) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 2c
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 2c). Sci Rep (2018) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 小鼠; 图 3c
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在小鼠样本上 (图 3c). Sci Rep (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD38抗体(BD Biosciences, 555462)被用于被用于流式细胞仪在人类样本上 (图 1a). J Clin Invest (2018) ncbi
小鼠 单克隆(HB7)
碧迪BD CD38抗体(BD Biosciences, HB7)被用于. Cell Stem Cell (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD38抗体(BD Biosciences, 555460)被用于被用于流式细胞仪在人类样本上 (图 2a). J Virol (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD38抗体(BD Biosciences, 562445)被用于被用于流式细胞仪在人类样本上 (图 1a). Front Immunol (2018) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s7j
碧迪BD CD38抗体(BD, 555462)被用于被用于流式细胞仪在人类样本上 (图 s7j). Nat Med (2018) ncbi
小鼠 单克隆(22/CD38)
  • 免疫印迹基因敲除验证; 人类; 图 2d
碧迪BD CD38抗体(Becton Dickinson, 611114)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 2d). Sci Rep (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD38抗体(Becton Dickinson, 555460)被用于被用于流式细胞仪在人类样本上 (图 3a). Sci Rep (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:10; 图 s2
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:10 (图 s2). Nat Commun (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 3d). Nature (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3d). Nature (2017) ncbi
小鼠 单克隆(HIT2)
  • 其他; 人类; 图 s1
  • 酶联免疫吸附测定; 人类; 图 st2
碧迪BD CD38抗体(BD/Pharm, 555458)被用于被用于其他在人类样本上 (图 s1) 和 被用于酶联免疫吸附测定在人类样本上 (图 st2). Cell Chem Biol (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD38抗体(BD Pharmingen, 335808)被用于被用于流式细胞仪在人类样本上 (图 s2). Scand J Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s9
碧迪BD CD38抗体(BD, 555461)被用于被用于流式细胞仪在人类样本上 (表 s9). Nature (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(Pharmingen, HB7)被用于被用于流式细胞仪在人类样本上. Oncol Lett (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 2a). Clin Immunol (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Bioscience, HIT2)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD38抗体(BD Bioscience, 345806)被用于被用于流式细胞仪在人类样本上 (图 4a). Sci Rep (2017) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2c
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 2c). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:200; 图 s1c
碧迪BD CD38抗体(BD, 335790)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 s1c). Nature (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s12b
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s12b). J Clin Invest (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 e7a
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 e7a). Nature (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD38抗体(BD Pharmingen, HIT2)被用于被用于流式细胞仪在人类样本上 (表 3). Brain Behav (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3c
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3c). J Biol Chem (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD38抗体(BD, 562288)被用于被用于流式细胞仪在人类样本上 (图 4a). J Virol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a, s4
碧迪BD CD38抗体(BD Biosciences, 562444)被用于被用于流式细胞仪在人类样本上 (图 1a, s4). JCI Insight (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 1a, s4
碧迪BD CD38抗体(BD Biosciences, 335790)被用于被用于流式细胞仪在人类样本上 (图 1a, s4). JCI Insight (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD38抗体(BD Biosciences, 551400)被用于被用于流式细胞仪在人类样本上 (图 st1). PLoS ONE (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:50
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上浓度为1:50. Nat Commun (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 st9
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 st9). JCI Insight (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD38抗体(Becton Dickinson, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1a). PLoS ONE (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, 340926)被用于被用于流式细胞仪在人类样本上. Oncol Lett (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上 (图 3a). Angiogenesis (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:50; 图 1
碧迪BD CD38抗体(BD, 555462)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 s2). Sci Rep (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD38抗体(Becton Dickinson, 551400)被用于被用于流式细胞仪在人类样本上 (图 1). Blood (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:50; 图 5f
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 5f). Nat Med (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:100; 图 1b
碧迪BD CD38抗体(BD, 560677)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 1b). Nat Cell Biol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
  • 免疫细胞化学; 人类; 图 4
碧迪BD CD38抗体(BD, HIT-2)被用于被用于流式细胞仪在人类样本上 (图 1) 和 被用于免疫细胞化学在人类样本上 (图 4). JCI Insight (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 e1c
碧迪BD CD38抗体(BD biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 e1c). Nature (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 1b
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上 (图 1b). Cancer Med (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s2
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s2). Eur J Immunol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s2d
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s2d). J Immunol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 9a
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上 (图 9a). J Exp Med (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s4
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s4). Oncotarget (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; baboons; 图 5
碧迪BD CD38抗体(Pharmingen, 561106)被用于被用于流式细胞仪在baboons样本上 (图 5). Nat Commun (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 小鼠; 图 7d
  • 流式细胞仪; 人类; 图 7c
碧迪BD CD38抗体(BD Biosciences, 562444)被用于被用于流式细胞仪在小鼠样本上 (图 7d) 和 被用于流式细胞仪在人类样本上 (图 7c). J Biol Chem (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 1:20; 图 1
碧迪BD CD38抗体(BD Pharmingen, 555461)被用于被用于流式细胞仪在人类样本上浓度为1:20 (图 1). Mol Med Rep (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD38抗体(BD, 555460)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD38抗体(BD, 555459)被用于被用于流式细胞仪在人类样本上 (图 2). Oncoimmunology (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 7c
碧迪BD CD38抗体(Becton Dickinson, 345806)被用于被用于流式细胞仪在人类样本上 (图 7c). BMC Biotechnol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 s1
碧迪BD CD38抗体(BD Pharmingen, BD555459)被用于被用于流式细胞仪在人类样本上 (表 s1). Stem Cells (2016) ncbi
小鼠 单克隆(HB7)
  • 其他; 人类; 图 st1
  • 流式细胞仪; 人类; 图 st3
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于其他在人类样本上 (图 st1) 和 被用于流式细胞仪在人类样本上 (图 st3). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上 (图 1). Cytometry B Clin Cytom (2017) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s1a, s1b, s1c
碧迪BD CD38抗体(BD, 335790)被用于被用于流式细胞仪在人类样本上 (图 s1a, s1b, s1c). Science (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 s3). Sci Transl Med (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上. Am J Transplant (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, # 555462)被用于被用于流式细胞仪在人类样本上. Immunol Res (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s4
碧迪BD CD38抗体(BD Biosciences, 563965)被用于被用于流式细胞仪在人类样本上 (图 s4). Nature (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 s5
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 s5). PLoS Pathog (2015) ncbi
小鼠 单克隆(22/CD38)
  • 免疫印迹; 人类
碧迪BD CD38抗体(BD Pharmingen, 611114)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Pharmingen, 555460)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3a). PLoS Negl Trop Dis (2015) ncbi
小鼠 单克隆(HIT2)
  • 免疫细胞化学; 人类; 图 6
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于免疫细胞化学在人类样本上 (图 6). Oncogene (2016) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry B Clin Cytom (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). Mucosal Immunol (2016) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD38抗体(BD Bioscience, 560677)被用于被用于流式细胞仪在人类样本上 (图 1). J Hematol Oncol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, 555458)被用于被用于流式细胞仪在人类样本上. MAbs (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 s3). J Immunol (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 表 s1
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 1:100
碧迪BD CD38抗体(BD, 335790)被用于被用于流式细胞仪在人类样本上浓度为1:100. Cell Stem Cell (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 6
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 6). Am J Hum Genet (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 3
碧迪BD CD38抗体(BD Pharmingen, HIT2)被用于被用于流式细胞仪在人类样本上 (图 3). Blood (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 st3
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 st3). AIDS (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Pharmingen, HIT2)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2015) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上. Eur J Cancer (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 表 2
碧迪BD CD38抗体(BD Bioscience, HB7)被用于被用于流式细胞仪在人类样本上 (表 2). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 4 ul per test
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上浓度为4 ul per test. Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(HIT2)
  • 免疫细胞化学; 小鼠
碧迪BD CD38抗体(PharMingen, HIT2)被用于被用于免疫细胞化学在小鼠样本上. Hum Pathol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD, HB7)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, HIT2)被用于被用于流式细胞仪在人类样本上. FASEB J (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(Becton Dickinson, HIT2)被用于被用于流式细胞仪在人类样本上. Biomed Res Int (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD38抗体(BD, HIT2)被用于被用于流式细胞仪在人类样本上 (表 1). Nat Immunol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD38抗体(BD, HB-7)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Immunol Immunother (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD38抗体(Becton Dickinson, HIT2)被用于被用于流式细胞仪在人类样本上 (图 1a). Clin Immunol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD38抗体(BD Biosciences, HB7)被用于被用于流式细胞仪在人类样本上 (图 2a). Blood (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Biosciences, HB-7)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2014) ncbi
小鼠 单克隆(HB7)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD38抗体(BD, clone HB7)被用于被用于流式细胞仪在人类样本上 (表 1). Cytopathology (2014) ncbi
小鼠 单克隆(HIT2)
  • 流式细胞仪; 人类
碧迪BD CD38抗体(BD Pharmingen, HIT2)被用于被用于流式细胞仪在人类样本上. Genes Dev (2009) ncbi
文章列表
  1. Delgobo M, Mendes D, Kozlova E, Rocha E, Rodrigues Luiz G, Mascarin L, et al. An evolutionary recent IFN/IL-6/CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. elife. 2019;8: pubmed 出版商
  2. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed 出版商
  3. Meckiff B, Ladell K, McLaren J, Ryan G, Leese A, James E, et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells. J Immunol. 2019;203:1276-1287 pubmed 出版商
  4. Hill D, Pierson W, Bolland D, Mkindi C, Carr E, Wang J, et al. The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes. J Exp Med. 2019;: pubmed 出版商
  5. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed 出版商
  6. Davis C, Jackson K, McElroy A, Halfmann P, Huang J, Chennareddy C, et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Cell. 2019;: pubmed 出版商
  7. Moffett H, Harms C, Fitzpatrick K, Tooley M, Boonyaratanakornkit J, Taylor J. B cells engineered to express pathogen-specific antibodies protect against infection. Sci Immunol. 2019;4: pubmed 出版商
  8. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed 出版商
  9. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed 出版商
  10. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed 出版商
  11. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed 出版商
  12. Lu E, Wolfreys F, Muppidi J, Xu Y, Cyster J. S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8. Nature. 2019;: pubmed 出版商
  13. van Galen P, Hovestadt V, Wadsworth Ii M, Hughes T, Griffin G, Battaglia S, et al. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. Cell. 2019;176:1265-1281.e24 pubmed 出版商
  14. Kriegsmann K, Baertsch M, Awwad M, Merz M, Hose D, Seckinger A, et al. Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients. Blood Cancer J. 2019;9:13 pubmed 出版商
  15. Ge Y, Schuster M, Pundhir S, Rapin N, Bagger F, Sidiropoulos N, et al. The splicing factor RBM25 controls MYC activity in acute myeloid leukemia. Nat Commun. 2019;10:172 pubmed 出版商
  16. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed 出版商
  17. Bradley T, Peppa D, Pedroza Pacheco I, Li D, Cain D, Henao R, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. 2018;175:387-399.e17 pubmed 出版商
  18. Al Maskari M, Care M, Robinson E, Cocco M, Tooze R, Doody G. Site-1 protease function is essential for the generation of antibody secreting cells and reprogramming for secretory activity. Sci Rep. 2018;8:14338 pubmed 出版商
  19. Dam E, Maier A, Hocking A, Carlin J, Buckner J. Increased Binding of Specificity Protein 1 to the IL21R Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid Arthritis. Front Immunol. 2018;9:1978 pubmed 出版商
  20. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed 出版商
  21. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed 出版商
  22. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed 出版商
  23. Heshmati Y, Kharazi S, Türköz G, Chang D, Kamali Dolatabadi E, Boström J, et al. The histone chaperone NAP1L3 is required for haematopoietic stem cell maintenance and differentiation. Sci Rep. 2018;8:11202 pubmed 出版商
  24. Moysi E, Pallikkuth S, de Armas L, Gonzalez L, Ambrozak D, George V, et al. Altered immune cell follicular dynamics in HIV infection following influenza vaccination. J Clin Invest. 2018;128:3171-3185 pubmed 出版商
  25. Weniger M, Tiacci E, Schneider S, Arnolds J, Rüschenbaum S, Duppach J, et al. Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells. J Clin Invest. 2018;128:2996-3007 pubmed 出版商
  26. Ferrara F, Kolnik M, D Angelo S, Erasmus F, Vorholt D, Bradbury A. Rapid purification of billions of circulating CD19+ B cells directly from leukophoresis samples. N Biotechnol. 2018;46:14-21 pubmed 出版商
  27. Baumgartner C, Toifl S, Farlik M, Halbritter F, Scheicher R, Fischer I, et al. An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion. Cell Stem Cell. 2018;22:879-892.e6 pubmed 出版商
  28. Sullivan N, Reuter Monslow M, Sei J, Durr E, Davis C, Chang C, et al. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. J Virol. 2018;92: pubmed 出版商
  29. Roders N, Herr F, Ambroise G, Thaunat O, Portier A, Vazquez A, et al. SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production. Front Immunol. 2018;9:787 pubmed 出版商
  30. Zhang Y, Xia F, Liu X, Yu Z, Xie L, Liu L, et al. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/?-catenin/CCND1 signaling. J Clin Invest. 2018;128:1737-1751 pubmed 出版商
  31. Khajuria R, Munschauer M, Ulirsch J, Fiorini C, Ludwig L, McFarland S, et al. Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis. Cell. 2018;173:90-103.e19 pubmed 出版商
  32. Zhang B, Nguyen L, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450-462 pubmed 出版商
  33. Gee M, Han A, Lofgren S, Beausang J, Mendoza J, Birnbaum M, et al. Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell. 2018;172:549-563.e16 pubmed 出版商
  34. Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed 出版商
  35. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed 出版商
  36. Macdonald R, Shrimp J, Jiang H, Zhang L, Lin H, Yen A. Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout. Sci Rep. 2017;7:17406 pubmed 出版商
  37. Buffone A, Anderson N, Hammer D. Migration against the direction of flow is LFA-1-dependent in human hematopoietic stem and progenitor cells. J Cell Sci. 2018;131: pubmed 出版商
  38. Arthur Huang K, Chen M, Huang Y, Shih S, Chiu C, Lin J, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8:762 pubmed 出版商
  39. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed 出版商
  40. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed 出版商
  41. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed 出版商
  42. Arumugakani G, Stephenson S, Newton D, Rawstron A, Emery P, Doody G, et al. Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition. J Immunol. 2017;198:4618-4628 pubmed 出版商
  43. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed 出版商
  44. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  45. Pérez Martínez C, Maravillas Montero J, Meza Herrera I, Vences Catalan F, Zlotnik A, Santos Argumedo L. Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression. Scand J Immunol. 2017;86:23-30 pubmed 出版商
  46. Dourado K, Baik J, Oliveira V, Beltrame M, Yamamoto A, Theuer C, et al. Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models. Blood. 2017;129:2526-2536 pubmed 出版商
  47. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed 出版商
  48. Pinto Cardoso S, Lozupone C, Briceno O, Alva Hernández S, Téllez N, Adriana A, et al. Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens. Sci Rep. 2017;7:43741 pubmed 出版商
  49. Vernot J, Bonilla X, Rodriguez Pardo V, Vanegas N. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment. Int J Mol Sci. 2017;18: pubmed 出版商
  50. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed 出版商
  51. Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110-114 pubmed 出版商
  52. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed 出版商
  53. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed 出版商
  54. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed 出版商
  55. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed 出版商
  56. van Andel H, Ren Z, Koopmans I, Joosten S, Kocemba K, de Lau W, et al. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins. Proc Natl Acad Sci U S A. 2017;114:376-381 pubmed 出版商
  57. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  58. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed 出版商
  59. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed 出版商
  60. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed 出版商
  61. Ng S, Mitchell A, Kennedy J, Chen W, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433-437 pubmed 出版商
  62. Briceno O, Pinto Cardoso S, Rodríguez Bernabe N, Murakami Ogasawara A, Reyes Teran G. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment. PLoS ONE. 2016;11:e0166496 pubmed 出版商
  63. Baker J, Nederveen J, Parise G. Aerobic exercise in humans mobilizes HSCs in an intensity-dependent manner. J Appl Physiol (1985). 2017;122:182-190 pubmed 出版商
  64. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed 出版商
  65. Dever D, Bak R, Reinisch A, Camarena J, Washington G, Nicolas C, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539:384-389 pubmed 出版商
  66. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  67. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  68. Fatehchand K, McMichael E, Reader B, Fang H, Santhanam R, Gautam S, et al. Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells. J Biol Chem. 2016;291:25656-25666 pubmed
  69. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  70. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed 出版商
  71. Alivernini S, Kurowska Stolarska M, Tolusso B, Benvenuto R, Elmesmari A, Canestri S, et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat Commun. 2016;7:12970 pubmed 出版商
  72. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed 出版商
  73. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  74. Lu X, Chen Q, Rong Y, Yang G, Li C, Xu N, et al. LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. Nat Commun. 2016;7:12719 pubmed 出版商
  75. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  76. Toro J, Salgado D, Vega R, Rodríguez J, Rodríguez L, Angel J, et al. Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections. PLoS ONE. 2016;11:e0161795 pubmed 出版商
  77. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed 出版商
  78. Coccaro N, Tota G, Anelli L, Zagaria A, Casieri P, Cellamare A, et al. MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32). Oncol Lett. 2016;12:1460-1464 pubmed
  79. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed 出版商
  80. Ebert L, Tan L, Johan M, Min K, Cockshell M, Parham K, et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis. 2016;19:463-86 pubmed 出版商
  81. van Wilgenburg B, Scherwitzl I, Hutchinson E, Leng T, Kurioka A, Kulicke C, et al. MAIT cells are activated during human viral infections. Nat Commun. 2016;7:11653 pubmed 出版商
  82. Nejedlá M, Sadi S, Sulimenko V, de Almeida F, Blom H, Draber P, et al. Profilin connects actin assembly with microtubule dynamics. Mol Biol Cell. 2016;27:2381-93 pubmed 出版商
  83. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed 出版商
  84. Sinclair A, Park L, Shah M, Drotar M, Calaminus S, Hopcroft L, et al. CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood. 2016;128:371-83 pubmed 出版商
  85. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed 出版商
  86. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed 出版商
  87. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  88. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed 出版商
  89. Rentas S, Holzapfel N, Belew M, Pratt G, Voisin V, Wilhelm B, et al. Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells. Nature. 2016;532:508-511 pubmed 出版商
  90. Saxena S, Ronn R, Guibentif C, Moraghebi R, Woods N. Cyclic AMP Signaling through Epac Axis Modulates Human Hemogenic Endothelium and Enhances Hematopoietic Cell Generation. Stem Cell Reports. 2016;6:692-703 pubmed 出版商
  91. Lisenko K, Schonland S, Jauch A, Andrulis M, Rocken C, Ho A, et al. Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis. Cancer Med. 2016;5:1464-72 pubmed 出版商
  92. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed 出版商
  93. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed 出版商
  94. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  95. Jackson S, Jacobs H, Arkatkar T, Dam E, Scharping N, Kolhatkar N, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733-50 pubmed 出版商
  96. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed 出版商
  97. Jourdan M, Cren M, Schafer P, Robert N, Duperray C, Vincent L, et al. Differential effects of lenalidomide during plasma cell differentiation. Oncotarget. 2016;7:28096-111 pubmed 出版商
  98. Brown P, Gascoyne D, Lyne L, Spearman H, Felce S, McFadden N, et al. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. Haematologica. 2016;101:861-71 pubmed 出版商
  99. Mohiuddin M, Singh A, Corcoran P, Thomas Iii M, Clark T, Lewis B, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat Commun. 2016;7:11138 pubmed 出版商
  100. Griffiths K, Dolezal O, Cao B, Nilsson S, See H, Pfleger K, et al. i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4. J Biol Chem. 2016;291:12641-57 pubmed 出版商
  101. Lee J, Han A, Lee S, Min W, Kim H. Co-culture with podoplanin+ cells protects leukemic blast cells with leukemia-associated antigens in the tumor microenvironment. Mol Med Rep. 2016;13:3849-57 pubmed 出版商
  102. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  103. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed 出版商
  104. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  105. Klose D, Saunders U, Barth S, Fischer R, Jacobi A, Nachreiner T. Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen. BMC Biotechnol. 2016;16:18 pubmed 出版商
  106. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed 出版商
  107. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed 出版商
  108. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed 出版商
  109. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  110. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed 出版商
  111. Lisenko K, Schönland S, Hegenbart U, Wallenwein K, Braun U, Mai E, et al. Potential therapeutic targets in plasma cell disorders: A flow cytometry study. Cytometry B Clin Cytom. 2017;92:145-152 pubmed 出版商
  112. Notta F, Zandi S, Takayama N, Dobson S, Gan O, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351:aab2116 pubmed 出版商
  113. Jackson J, Taylor J, Witek M, Hunsucker S, Waugh J, Fedoriw Y, et al. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood. Analyst. 2016;141:640-51 pubmed 出版商
  114. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed 出版商
  115. Newell K, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, et al. Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am J Transplant. 2015;15:2908-20 pubmed 出版商
  116. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed 出版商
  117. Monahan R, Stein A, Gibbs K, Bank M, Bloom O. Circulating T cell subsets are altered in individuals with chronic spinal cord injury. Immunol Res. 2015;63:3-10 pubmed 出版商
  118. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed 出版商
  119. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed 出版商
  120. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed 出版商
  121. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed 出版商
  122. Japp A, Kursunel M, Meier S, Mälzer J, Li X, Rahman N, et al. Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression. Cancer Immunol Immunother. 2015;64:1487-94 pubmed 出版商
  123. Bunaciu R, Jensen H, Macdonald R, Latocha D, Varner J, Yen A. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells. PLoS ONE. 2015;10:e0135668 pubmed 出版商
  124. Lorkova L, Scigelova M, Arrey T, Vit O, Pospisilova J, Doktorova E, et al. Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells. PLoS ONE. 2015;10:e0135314 pubmed 出版商
  125. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed 出版商
  126. Nishioka C, Ikezoe T, Takeuchi A, Nobumoto A, Tsuda M, Yokoyama A. The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells. Leukemia. 2015;29:2296-306 pubmed 出版商
  127. Ahn J, Li J, Chen E, Kent D, Park H, Green A. JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation. Oncogene. 2016;35:2235-46 pubmed 出版商
  128. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed 出版商
  129. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed 出版商
  130. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed 出版商
  131. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed 出版商
  132. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed 出版商
  133. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed 出版商
  134. Holzapfel B, Hutmacher D, Nowlan B, Barbier V, Thibaudeau L, Theodoropoulos C, et al. Tissue engineered humanized bone supports human hematopoiesis in vivo. Biomaterials. 2015;61:103-14 pubmed 出版商
  135. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed 出版商
  136. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed 出版商
  137. Esch M, Prot J, Wang Y, Miller P, Llamas Vidales J, NAUGHTON B, et al. Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. Lab Chip. 2015;15:2269-77 pubmed 出版商
  138. Castiello M, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, et al. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;136:692-702.e2 pubmed 出版商
  139. Tian X, Zhang A, Qiu C, Wang W, Yang Y, Qiu C, et al. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects. J Immunol. 2015;194:3873-82 pubmed 出版商
  140. Overdijk M, Verploegen S, Bögels M, van Egmond M, Lammerts van Bueren J, Mutis T, et al. Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma. MAbs. 2015;7:311-21 pubmed 出版商
  141. Inui M, Hirota S, Hirano K, Fujii H, Sugahara Tobinai A, Ishii T, et al. Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals. Int Immunol. 2015;27:345-55 pubmed 出版商
  142. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed 出版商
  143. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed 出版商
  144. Laurenti E, Frelin C, Xie S, Ferrari R, Dunant C, Zandi S, et al. CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell. 2015;16:302-13 pubmed 出版商
  145. Lewis M, Vyse S, Shields A, Boeltz S, Gordon P, Spector T, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221-34 pubmed 出版商
  146. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed 出版商
  147. de Masson A, Bouaziz J, Le Buanec H, Robin M, O Meara A, Parquet N, et al. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125:1830-9 pubmed 出版商
  148. Abdel Mohsen M, Wang C, Strain M, Lada S, Deng X, Cockerham L, et al. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS. 2015;29:411-20 pubmed 出版商
  149. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed 出版商
  150. Sun W, Wang Y, East J, Kimball A, Tkaczuk K, Kesmodel S, et al. Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional. Cytokine. 2015;72:48-57 pubmed 出版商
  151. Bürgler S, Gimeno A, Parente Ribes A, Wang D, Os A, Devereux S, et al. Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism. J Immunol. 2015;194:827-35 pubmed 出版商
  152. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed 出版商
  153. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed 出版商
  154. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  155. Stacchini A, Pacchioni D, Demurtas A, Aliberti S, Cassenti A, Isolato G, et al. Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas. Cytometry B Clin Cytom. 2015;88:320-9 pubmed 出版商
  156. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed 出版商
  157. Fernandez C, Amarasena T, Kelleher A, Rossjohn J, McCluskey J, Godfrey D, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015;93:177-88 pubmed 出版商
  158. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed 出版商
  159. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  160. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed 出版商
  161. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed 出版商
  162. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed 出版商
  163. Della Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015;74:2236-43 pubmed 出版商
  164. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed 出版商
  165. Chiu Y, Lin I, Su S, Wang K, Yang S, Tsai D, et al. Transcription factor ABF-1 suppresses plasma cell differentiation but facilitates memory B cell formation. J Immunol. 2014;193:2207-17 pubmed 出版商
  166. Kusner L, Ciesielski M, Marx A, Kaminski H, Fenstermaker R. Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study. PLoS ONE. 2014;9:e102231 pubmed 出版商
  167. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed 出版商
  168. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed 出版商
  169. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed 出版商
  170. Hoermann G, Blatt K, Greiner G, Putz E, Berger A, Herrmann H, et al. CD52 is a molecular target in advanced systemic mastocytosis. FASEB J. 2014;28:3540-51 pubmed 出版商
  171. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed 出版商
  172. Szánthó E, Bhattoa H, Csobán M, Antal Szalmas P, Ujfalusi A, Kappelmayer J, et al. Serum thymidine kinase activity: analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemia. PLoS ONE. 2014;9:e91647 pubmed 出版商
  173. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed 出版商
  174. Mueller A, Brieske C, Schinke S, Csernok E, Gross W, Hasselbacher K, et al. Plasma cells within granulomatous inflammation display signs pointing to autoreactivity and destruction in granulomatosis with polyangiitis. Arthritis Res Ther. 2014;16:R55 pubmed 出版商
  175. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed 出版商
  176. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed 出版商
  177. Frigyesi I, Adolfsson J, Ali M, Christophersen M, Johnsson E, Turesson I, et al. Robust isolation of malignant plasma cells in multiple myeloma. Blood. 2014;123:1336-40 pubmed 出版商
  178. Martinez Marignac V, Smith S, Toban N, Bazile M, Aloyz R. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming. Oncotarget. 2013;4:2550-66 pubmed
  179. Elias S, Choudhary P, de Cassan S, Biswas S, Collins K, Halstead F, et al. Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. Immunology. 2014;141:628-44 pubmed 出版商
  180. Lighaam L, Vermeulen E, Bleker T, Meijlink K, Aalberse R, Barnes E, et al. Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response. J Allergy Clin Immunol. 2014;133:267-70.e1-6 pubmed 出版商
  181. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed 出版商
  182. Stacchini A, Aliberti S, Pacchioni D, Demurtas A, Isolato G, Gazzera C, et al. Flow cytometry significantly improves the diagnostic value of fine needle aspiration cytology of lymphoproliferative lesions of salivary glands. Cytopathology. 2014;25:231-40 pubmed 出版商
  183. Nichele I, Zamo A, Bertolaso A, Bifari F, Tinelli M, Franchini M, et al. VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type. PLoS ONE. 2012;7:e52811 pubmed 出版商
  184. Manjarrez Orduno N, Marasco E, Chung S, Katz M, Kiridly J, Simpfendorfer K, et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet. 2012;44:1227-30 pubmed 出版商
  185. Zuo Z, Tang Y, Bi C, Zhang W, Zhao S, Wang X, et al. Extraosseous (extramedullary) plasmacytomas: a clinicopathologic and immunophenotypic study of 32 Chinese cases. Diagn Pathol. 2011;6:123 pubmed 出版商
  186. Doulatov S, Notta F, Rice K, Howell L, Zelent A, Licht J, et al. PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes Dev. 2009;23:2076-87 pubmed 出版商
  187. Park C, Majeti R, Weissman I. In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc. 2008;3:1932-40 pubmed 出版商
  188. Jacobi A, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum. 2008;58:1762-73 pubmed 出版商
  189. Friedrichs B, Siegel S, Kloess M, Barsoum A, Coggin J, Rohrer J, et al. Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia. J Immunol. 2008;180:6374-84 pubmed
  190. Diaz Blanco E, Bruns I, Neumann F, Fischer J, Graef T, Rosskopf M, et al. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007;21:494-504 pubmed
  191. Kolar G, Mehta D, Pelayo R, Capra J. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007;109:2545-52 pubmed
  192. Kolar G, Mehta D, Wilson P, Capra J. Diversity of the Ig repertoire is maintained with age in spite of reduced germinal centre cells in human tonsil lymphoid tissue. Scand J Immunol. 2006;64:314-24 pubmed
  193. Biedermann B, Gil D, Bowen D, Crocker P. Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors. Leuk Res. 2007;31:211-20 pubmed
  194. Jamieson C, Gotlib J, Durocher J, Chao M, Mariappan M, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224-9 pubmed
  195. Timeus F, Crescenzio N, Sanavio F, Fazio L, Doria A, Foglia L, et al. Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice. Haematologica. 2006;91:369-72 pubmed
  196. Ninos J, Jefferies L, Cogle C, Kerr W. The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells. J Transl Med. 2006;4:9 pubmed
  197. Crough T, Burrows J, Fazou C, Walker S, Davenport M, Khanna R. Contemporaneous fluctuations in T cell responses to persistent herpes virus infections. Eur J Immunol. 2005;35:139-49 pubmed
  198. Mateo G, Corral M, Almeida J, López Berges C, Nieto m, García Marcos A, et al. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma. Haematologica. 2003;88:1013-21 pubmed
  199. Ku C, Padilla J, Grose C, Butcher E, Arvin A. Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J Virol. 2002;76:11425-33 pubmed
  200. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, et al. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood. 2002;100:2562-71 pubmed
  201. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  202. Lewandowski D, Linassier C, Iochmann S, Degenne M, Domenech J, Colombat P, et al. Phosphatidylinositol 3-kinases are involved in the all-trans retinoic acid-induced upregulation of CD38 antigen on human haematopoietic cells. Br J Haematol. 2002;118:535-44 pubmed
  203. Zhang X, Dormady S, Basch R. Identification of four human cDNAs that are differentially expressed by early hematopoietic progenitors. Exp Hematol. 2000;28:1286-96 pubmed
  204. Barquinero J, Segovia J, Ramirez M, Limon A, Guenechea G, Puig T, et al. Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice. Blood. 2000;95:3085-93 pubmed
  205. Basch R, Zhang X, Dolzhanskiy A, Karpatkin S. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development. Br J Haematol. 1999;105:1044-54 pubmed
  206. Grammer A, McFarland R, Heaney J, Darnell B, Lipsky P. Expression, regulation, and function of B cell-expressed CD154 in germinal centers. J Immunol. 1999;163:4150-9 pubmed
  207. Denning Kendall P, Horsley H, Donaldson C, Bradley B, Hows J. Different behaviour of fresh and cultured CD34+ cells during immunomagnetic separation. Br J Haematol. 1999;105:780-5 pubmed
  208. Luque R, Brieva J, Moreno A, Manzanal A, Escribano L, Villarrubia J, et al. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications. Clin Exp Immunol. 1998;112:410-8 pubmed
  209. Hryhorenko E, Rittenhouse Diakun K, Harvey N, Morgan J, Stewart C, Oseroff A. Characterization of endogenous protoporphyrin IX induced by delta-aminolevulinic acid in resting and activated peripheral blood lymphocytes by four-color flow cytometry. Photochem Photobiol. 1998;67:565-72 pubmed
  210. Denning Kendall P, Nicol A, Horsley H, Donaldson C, Bradley B, Hows J. Is in vitro expansion of human cord blood cells clinically relevant?. Bone Marrow Transplant. 1998;21:225-32 pubmed
  211. van der Voort R, Taher T, Keehnen R, Smit L, Groenink M, Pals S. Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway. J Exp Med. 1997;185:2121-31 pubmed
  212. Muench M, Roncarolo M, Menon S, Xu Y, Kastelein R, Zurawski S, et al. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood. 1995;85:963-72 pubmed